Revenue, last quarter
$51.2K
+227.9% vs same quarter last year
Net income
−$3.2M
+29.2% vs same quarter last year
EPS, diluted
−$2.83
Operating cash flow
−$2.6M
+19.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $54.2K | −$8M |
| FY24 | $2.6M | −$30M |
| FY23 | $2.8M | −$25M |
| FY22 | $6.7M | −$14.9M |
| FY21 | $0 | −$12.9M |
| FY20 | $4.1M | −$5.8M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 20% | −24270.7% | −14677.1% |
| FY24 | 37.4% | −1147.6% | −1169.7% |
| FY23 | 19.7% | −905% | −879.5% |
| FY22 | 38.5% | −224.3% | −221.7% |
| FY21 | - | - | - |
| FY20 | - | −142.1% | −141.5% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$13.4M |
| FY24 | −$14.5M |
| FY23 | −$28.7M |
| FY22 | −$20.7M |
| FY21 | −$11M |
| FY20 | −$10.6M |
| FY19 | - |
- HCW Biologics
- Healthcare median
Show the numbers
| Year | HCW Biologics | Healthcare median |
|---|---|---|
| FY25 | −14677.1% | −30.6% |
| FY24 | −1169.7% | −47% |
| FY23 | −879.5% | −58% |
| FY22 | −221.7% | −80.4% |
| FY21 | - | −71.9% |
| FY20 | −141.5% | −62.2% |
| FY19 | - | −46.3% |